All News
Filter News
Found 808,991 articles
-
Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo 32mg Extended Release Tablets
11/27/2017
Exalgo 32mg extended release tablets C-II is an opioid agonist indicated for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
-
BASF to Increase Prices for Formic Acid and Propionic Acid in the EMEA Region
11/27/2017
Prices for all other concentrations of Formic Acid will be increased accordingly on a pro rata basis.
-
VANC Pharmaceuticals Plans to Launch INSTI HIV Test with United Pharma Group on World AIDS Day
11/27/2017
This represents the first time the Canadian public will have direct access to their HIV status within 60 seconds in a community pharmacy, since the program was successfully piloted in July 2014.
-
NYU Langone Health Release: Removing Chemical Used to Make Teflon-Like Coatings Has Led to Fewer Low Birth Weights and Less Brain Damage
11/27/2017
Scientists behind the research, conducted at NYU School of Medicine, say that studies have long linked the chemicals-famous for keeping food from sticking to pans-with high blood pressure, birth defects, and lower-than-normal birth weights.
-
Bio-Tissue Announces Study that Demonstrates Cryopreserved Amniotic Membrane Graft Reduces Recurrence After Pterygium Surgery
11/27/2017
In this retrospective review, 556 eyes representing 535 patients, who had pterygium excision (527 primary, 29 recurrent) were treated with adjunctive cryopreserved amniotic membrane.
-
Quadrant Biosciences Release: Salivary microRNA May Predict Duration and Nature of Concussion Symptoms Among Children
11/27/2017
Small molecules in saliva may hold the key to predicting the type and duration of concussion symptoms, according to a study just published in the JAMA.
-
Storm Therapeutics Announces Publication in Nature on RNA Epigenetics by Founder Professor Tony Kouzarides
11/27/2017
The study has found an unexpected new drug target for acute myeloid leukaemia that could open new avenues to develop effective treatments against this potentially lethal disease.
-
Avista Capital Partners to Acquire Express Scripts' Subsidiary United BioSource
11/27/2017
Centerview Partners LLC acted as financial advisor and Bryan Cave LLP acted as legal counsel to Express Scripts.
-
Skinvisible Announces Proposed Merger With Quoin Pharma
11/27/2017
Skinvisible announced that it has entered into a non-binding term sheet regarding a proposed merger of Skinvisible with and into Quoin Pharma subject to tax, accounting, legal, regulatory, and other considerations.
-
CanniMed Therapeutics Confirms Receipt of Unsolicited Offer From Aurora Cannabis
11/27/2017
Shareholders already have an attractive and accretive acquisition of Newstrike Resources available to them.
-
Orig3n Acquires Interleukin Genetics, a Genetics-Based Personalized Health Company, to Advance the Future of Health Faster
11/27/2017
The automated genotyping lab is fully-licensed for testing in all 50 U.S. states and is capable of processing over one million samples per year.
-
GENFIT: Contributing Significantly to the European LITMUS Initiative on NASH Biomarkers
11/27/2017
LITMUS (The Liver Investigation: Testing Marker Utility in Steatohepatitis) is a European consortium that brings together clinicians and scientists from prominent academic centers across Europe.
-
Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B
11/27/2017
Orchard Therapeutics announces today that it has acquired an exclusive license to develop lentivirus-based autologous ex-vivo gene therapy for Sanfilippo syndrome type B from The University of Manchester, UK.
-
Systech International and NKP Pharma Expand Presence in India to Deliver Pharmaceutical Serialization and Traceability Solutions
11/27/2017
The accord allows the two companies to provide software/hardware solutions to the Indian pharma industry that meet serialization and traceability regulations.
-
BioMed X and Boehringer Ingelheim Start New Joint Research Group in Bacterial Modulation of Innate Immunity
11/27/2017
The focus of the group will be to identify novel regulatory pathways within the innate immune system, through understanding molecular mechanisms employed by bacteria to evade or modulate innate immunity.
-
South Africa's CPGR to Partner With The Sunflower Fund to stimulate Medical Innovation in Africa Through Access to High-Resolution HLA Testing and Data Aggregation
11/27/2017
The CPGR today announced that it has entered into a partnership with TSF to make best-in-class stem-cell typing solutions available on the African continent.
-
Acerus Announces Licensing of NATESTO in Brazil
11/27/2017
Acerus will receive a non-refundable upfront fee, with a first installment paid at signing and the remaining payable upon regulatory approval.
-
HITGEN and Boehringer Ingelheim Enter DNA-Encoded Library Based Drug Discovery Research Collaboration
11/27/2017
HitGen will receive upfront payments, and be eligible for milestone payments from Boehringer Ingelheim. Specific financial details were not disclosed.
-
Inflection Biosciences and RCSI Enter Research Collaboration to Target Therapy-Resistant Breast Cancer
11/27/2017
Inflection Biosciences and RCSI, today announced a research collaboration that aims to understand mechanisms of resistance to major breast cancer therapies and examine potential new treatments of Inflection Biosciences for patients with a cancer that does not respond effectively to existing therapies.
-
Fresenius Medical Care Achieves Improved Health Outcomes and Savings Through National Medicare Demonstration Program
11/27/2017
This success was validated by an independent report from Lewin Group, which showed a nearly nine percent decrease in hospitalization rates for these patients during the same time.